NO993563L - Nye fettsyrederivater - Google Patents

Nye fettsyrederivater

Info

Publication number
NO993563L
NO993563L NO993563A NO993563A NO993563L NO 993563 L NO993563 L NO 993563L NO 993563 A NO993563 A NO 993563A NO 993563 A NO993563 A NO 993563A NO 993563 L NO993563 L NO 993563L
Authority
NO
Norway
Prior art keywords
fatty acid
acid derivatives
nonadecenyl
heptadecenyl
rch
Prior art date
Application number
NO993563A
Other languages
English (en)
Other versions
NO993563D0 (no
NO325518B1 (no
Inventor
Finn Myhren
Are Dalen
Bernt Boerretzen
Marit Liland Sandvold
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Publication of NO993563D0 publication Critical patent/NO993563D0/no
Publication of NO993563L publication Critical patent/NO993563L/no
Publication of NO325518B1 publication Critical patent/NO325518B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/252Naphthacene radicals, e.g. daunomycins, adriamycins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03Monocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/716Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C07C69/72Acetoacetic acid esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734Ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/88Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with esterified carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO19993563A 1997-01-24 1999-07-21 Nye fettsyrederivater NO325518B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9701441A GB2321455A (en) 1997-01-24 1997-01-24 Lipophilic derivatives of biologically active compounds
PCT/NO1998/000021 WO1998032718A1 (en) 1997-01-24 1998-01-23 New fatty acid derivatives

Publications (3)

Publication Number Publication Date
NO993563D0 NO993563D0 (no) 1999-07-21
NO993563L true NO993563L (no) 1999-09-17
NO325518B1 NO325518B1 (no) 2008-06-02

Family

ID=10806515

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19993563A NO325518B1 (no) 1997-01-24 1999-07-21 Nye fettsyrederivater

Country Status (23)

Country Link
US (3) US20010006962A1 (no)
EP (1) EP0977725B1 (no)
JP (2) JP4698773B2 (no)
KR (1) KR100546457B1 (no)
AT (1) ATE269292T1 (no)
AU (1) AU733370B2 (no)
CA (1) CA2276694C (no)
CZ (1) CZ299815B6 (no)
DE (1) DE69824574T2 (no)
DK (1) DK0977725T3 (no)
ES (1) ES2224356T3 (no)
GB (1) GB2321455A (no)
HU (1) HU225664B1 (no)
IL (1) IL130853A (no)
NO (1) NO325518B1 (no)
NZ (1) NZ336724A (no)
PL (1) PL196831B1 (no)
RU (1) RU2227794C2 (no)
SK (1) SK284803B6 (no)
TW (1) TWI231209B (no)
UA (1) UA65557C2 (no)
WO (1) WO1998032718A1 (no)
ZA (1) ZA98579B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
US6207700B1 (en) * 1999-01-07 2001-03-27 Vanderbilt University Amide derivatives for antiangiogenic and/or antitumorigenic use
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
US7816398B2 (en) * 2001-03-23 2010-10-19 Luitpold Pharmaceuticals, Inc. Fatty alcohol drug conjugates
JP2005500988A (ja) * 2001-03-23 2005-01-13 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド 脂肪族アミン薬物複合体
AU2003255851B2 (en) * 2002-07-08 2009-07-23 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. New compounds, compositions and methods for treatment of inflammatory diseases and conditions
AU2003255849A1 (en) * 2002-07-08 2004-01-23 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use
ATE429441T1 (de) * 2002-07-08 2009-05-15 Glaxosmithkline Zagreb Hybridmoleküle von makroliden mit steroidalen/nicht-steroidalen antientzündlich aktiven molekülen
WO2004033478A2 (en) 2002-10-08 2004-04-22 Sepracor Inc. Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory
US7196082B2 (en) * 2002-11-08 2007-03-27 Merck & Co. Inc. Ophthalmic compositions for treating ocular hypertension
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
JP2007534702A (ja) 2004-04-26 2007-11-29 バンダービルト・ユニバーシティ 胃腸毒性の低い治療薬としてのインドール酢酸、及びインデン酢酸誘導体
NO324263B1 (no) 2005-12-08 2007-09-17 Clavis Pharma Asa Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser
US8497292B2 (en) 2005-12-28 2013-07-30 Translational Therapeutics, Inc. Translational dysfunction based therapeutics
CN101528222A (zh) 2006-06-19 2009-09-09 范德比尔特大学 用于诊断性和治疗性靶向cox-2的方法和组合物
NO331891B1 (no) 2007-03-20 2012-04-30 Clavis Pharma Asa Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS
MX2010003261A (es) 2007-09-26 2010-08-18 Sinai School Medicine Analogos de azacitidina y usos de los mismos.
WO2010028458A1 (en) * 2008-09-12 2010-03-18 Parnell Laboratories (Aust) Pty Ltd Prodrugs of isoxazolyl penicillins and uses thereof
WO2011023573A1 (en) * 2009-08-26 2011-03-03 Basf Se Antimicrobial amino-salicylic acid derivatives
US20130150330A1 (en) * 2011-06-13 2013-06-13 University Of Kansas Decoquinate prodrugs
WO2013059245A1 (en) 2011-10-17 2013-04-25 Vanderbilt University Indomethacin analogs for the treatment of castrate-resistant prostate cancer
US9428477B2 (en) 2012-04-27 2016-08-30 Nippon Zoki Pharmaceutical Co., Ltd. Trans-2-decenoic acid derivative and drug containing same
CN103450141B (zh) * 2013-08-23 2015-08-26 山东鲁抗舍里乐药业有限公司 一种苯并吡喃酮类化合物、其制备方法及其应用
CN110582480B (zh) 2017-04-21 2023-11-10 塔斯马尼亚大学 治疗化合物和方法
CN111116374B (zh) * 2019-12-04 2020-12-15 北京理工大学 一种氨鲁米特与2-硝基苯甲酸合成π-π键共晶体的方法
JP7231576B2 (ja) 2020-03-09 2023-03-01 株式会社日立ハイテク 電解質濃度測定装置

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2933380A (en) * 1955-06-22 1960-04-19 Du Pont Motor fuels
GB1269942A (en) * 1968-07-25 1972-04-06 Murphy Chemical Ltd Improvements in or relating to pesticides
GB1325798A (en) * 1970-09-24 1973-08-08 Upjohn Co Derivatives of 2,2-anhydro-ara-cytidine
IT1043956B (it) 1970-10-17 1980-02-29 Isf Spa 21 esteri di acidi grassi insaturi del desa e beta metazone
JPS4882023A (no) * 1972-02-04 1973-11-02
JPS50129584A (no) * 1974-03-25 1975-10-13
CA1113486A (en) * 1977-04-01 1981-12-01 Alfred Halpern Ultra-violet filtration with certain aminosalicylic acid esters
FR2485001A1 (fr) * 1980-06-02 1981-12-24 Svatos Antonin Esters de l'acide ricinoleique et de chloroxylenols et compositions antiparasitaires
US4436726A (en) * 1980-12-15 1984-03-13 Fujisawa Pharmaceutical Co., Ltd. N-Acylpeptide compound, processes for the preparation thereof and the pharmaceutical compositions
US4554279A (en) * 1981-01-29 1985-11-19 The United States Of America As Represented By The Secretary Of The Army 5-(Straight chain 3-12 carbon alkoxy)-8-quinolinamines and their use for treatment of malaria
EP0105404A1 (en) * 1982-09-30 1984-04-18 Merck & Co. Inc. Derivatives of steroid compounds linked to cyotoxic agents and process for their preparation
US4551279A (en) * 1984-01-09 1985-11-05 G. D. Searle & Co. Protease inhibitors
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters
JPS61204197A (ja) * 1985-03-06 1986-09-10 Yoshikawa Seiyu Kk ステロ−ル脂肪酸エステルの製造方法
ZA852614B (en) * 1985-05-17 1986-10-09 Takeda Chemical Industries, Ltd. Ascorbic acid ethers and their production
GB2178031B (en) * 1985-06-10 1989-07-26 Procter & Gamble Phenylacetic acid amides having anti-inflammatory and analgesic activity
US4722927A (en) * 1986-04-28 1988-02-02 Warner-Lambert Company Pyrimidine amides of oleic or linoleic acid, composition containing them and their use as inhibitors of acyl-CoA cholesterol acyltransferase
DE3625738A1 (de) * 1986-07-30 1988-02-11 Goedecke Ag 2-acyloxypropylamin-derivate, verfahren zu deren herstellung und deren verwendung
ES2061624T3 (es) * 1987-03-09 1994-12-16 Procter & Gamble Compuestos fenilicos sustituidos con amino-etilo en posicion beta, y composiciones anti-inflamatorias o analgesicas que los contienen.
JPH0196158A (ja) * 1987-10-09 1989-04-14 Santen Pharmaceut Co Ltd 抗炎症剤
US5284876A (en) * 1988-02-26 1994-02-08 Neuromedica, Inc. Method of treating tardive dyskinesia using dopaminergic agents of prodrugs of therapeutic agents
DE3826846A1 (de) * 1988-08-06 1990-02-08 Goedecke Ag Alkoxy-4(1h)-pyridon-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
US5135736A (en) * 1988-08-15 1992-08-04 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
JPH02212488A (ja) * 1989-02-13 1990-08-23 Shinichiro Shimizu トリアゾールピリミジン誘導体
JPH0381286A (ja) * 1989-08-22 1991-04-05 Green Cross Corp:The ステロイド外用剤
CA2037957A1 (en) * 1990-03-12 1991-09-13 Merck & Co., Inc. N-acylated cyclohexapeptide compounds
FR2664500B1 (fr) * 1990-07-13 1994-10-28 Lille Ii Universite Droit Sant Procede de preparation d'une lipoproteine modifiee par incorporation d'une substance active lipophile, lipoproteine modifiee ainsi obtenue et composition pharmaceutique ou cosmetique la contenant.
WO1992003131A1 (en) * 1990-08-13 1992-03-05 G.D. Searle & Co. Use of heterocyclic amino-alcohol compounds for treatment of cns diseases
US5242945A (en) * 1991-04-12 1993-09-07 American Home Products Corporation Tetronic and thiotetronic acid derivatives as phospholipase a2 inhibitors
GB2260319B (en) * 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
US5238933A (en) * 1991-10-28 1993-08-24 Sri International Skin permeation enhancer compositions
AU3892593A (en) * 1992-04-08 1993-11-18 Paavo Kai Johannes Kinnunen Composition for therapeutic or diagnostic use, process for its preparation and its use
US5324747A (en) * 1992-07-15 1994-06-28 Hoffmann-La Roche Inc. N-substituted anilines, inhibitors of phospholipases A2
US5807884A (en) * 1992-10-30 1998-09-15 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5466685A (en) * 1993-05-13 1995-11-14 Johnson & Johnson Inhibition of expression of beta-lactamase using esters of fatty acid alcohols
ES2270426T3 (es) * 1994-03-18 2007-04-01 Supernus Pharmaceuticals, Inc. Sistema de suministros de farmacos emulsionados.
US5447729A (en) * 1994-04-07 1995-09-05 Pharmavene, Inc. Multilamellar drug delivery systems
US5580899A (en) * 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives
JPH08217787A (ja) * 1995-02-15 1996-08-27 Meiji Seika Kaisha Ltd 脂溶性アントラサイクリン誘導体
JPH08325154A (ja) * 1995-03-31 1996-12-10 Mitsui Toatsu Chem Inc 安息香酸誘導体およびそれを有効成分として含有するホスホリパーゼa2阻害剤
DE69626927T2 (de) * 1995-10-30 2003-11-20 Oleoyl Estrone Developments S Oleat Monoester von Estrogenen zur Behandlung von Fettleibigkeit

Also Published As

Publication number Publication date
HUP0000937A2 (hu) 2000-09-28
EP0977725B1 (en) 2004-06-16
IL130853A (en) 2005-03-20
KR100546457B1 (ko) 2006-01-26
CA2276694C (en) 2007-05-22
JP5232083B2 (ja) 2013-07-10
SK284803B6 (sk) 2005-11-03
CZ299815B6 (cs) 2008-12-03
DK0977725T3 (da) 2004-09-13
US20010006962A1 (en) 2001-07-05
UA65557C2 (uk) 2004-04-15
PL334919A1 (en) 2000-03-27
AU733370B2 (en) 2001-05-10
ZA98579B (en) 1998-07-23
PL196831B1 (pl) 2008-02-29
CA2276694A1 (en) 1998-07-30
SK100399A3 (en) 2000-01-18
AU5782898A (en) 1998-08-18
DE69824574T2 (de) 2005-07-14
WO1998032718A1 (en) 1998-07-30
GB9701441D0 (en) 1997-03-12
JP4698773B2 (ja) 2011-06-08
US6762175B2 (en) 2004-07-13
US20030153544A1 (en) 2003-08-14
HU225664B1 (en) 2007-05-29
DE69824574D1 (de) 2004-07-22
JP2001522351A (ja) 2001-11-13
JP2009280583A (ja) 2009-12-03
KR20000070317A (ko) 2000-11-25
NZ336724A (en) 2001-06-29
RU2227794C2 (ru) 2004-04-27
US20040063677A1 (en) 2004-04-01
ES2224356T3 (es) 2005-03-01
ATE269292T1 (de) 2004-07-15
NO993563D0 (no) 1999-07-21
TWI231209B (en) 2005-04-21
IL130853A0 (en) 2001-01-28
HUP0000937A3 (en) 2001-01-29
NO325518B1 (no) 2008-06-02
EP0977725A1 (en) 2000-02-09
CZ247799A3 (cs) 2000-02-16
GB2321455A (en) 1998-07-29

Similar Documents

Publication Publication Date Title
DK0977725T3 (da) Nye fedtsyrederivater
DE68909139T2 (de) Substanz FR901228 und deren Herstellung.
FR2756181B1 (fr) Composition cosmetique, pharmaceutique a base de culture inactivee de bacteries bifidobacterium, d'huile de menthe et d'un acide
DE69604714T2 (de) Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen
ATE38834T1 (de) 5-substituierte 1,2,4-oxadiazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
RU94031754A (ru) Ароматические производные карбоновой кислоты
GT199800196A (es) Combinaciones de estatina-eter carboxialquilico.
KR910014395A (ko) 신규 화합물
ES2196187T3 (es) Conjugados peptidicos derivados de las hormonas timicas, su utilizacion a titulo de medicamento y composiciones que los contienen.
ATE160338T1 (de) Alpha aminosäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
FI963440A0 (fi) Uudet aminohappojohdannaiset, näiden valmistusmenetelmä ja näitä yhdisteitä sisältävät farmaseuttiset seokset
FR2707089B1 (fr) Nouveaux dérivés d'acide phosphonique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ID25870A (id) Zat thiksotropik berdasarkan resin alkid
DE68906572T2 (de) Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
BR9811954A (pt) ácidos 3-aril-succinamido-hidroxâmicos, processos para sua produção e preparações farmacêuticas contendo estas substâncias
RU94000064A (ru) Новые 2-циано-3-гидроксипропенамиды, метод их получения и содержащие их фармацевтические композиции
FR2679907B1 (fr) Nouveaux n-[(isoquinolein-5 yl)sulfonyl] azacycloalcanes, leur procede de preparation et les compositions pharmaceutiques les contenant.
DE59004292D1 (de) Renin-hemmende Aminooligohydroxy-Derivate.
EA199700302A1 (ru) Биологически активные уреидо-производные, полезные при лечении рассеянного склероза
BR9813102A (pt) Derivados de ácido metilenobisfosfÈnico novos
DE68909451D1 (de) Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
AR023938A1 (es) Composiciones estables de aminobutironitrilo quiral.
RU95101846A (ru) Полизамещенные производные 3-ациламино-5-фенил-1,4-бензодиазепин-2-она, способ их получения и содержащая их фармацевтическая композиция
GT199400018A (es) Corticosteroide-17-alquilcarbonato-21-(0)-esteres de acido carboxilico y carbonico, procedimientos para su preparacion y medicamentos que los contienen

Legal Events

Date Code Title Description
MK1K Patent expired